FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2087416757> ?p ?o ?g. }

• W2087416757 endingPage "1282" @default.
• W2087416757 startingPage "1276" @default.
• W2087416757 abstract "Abstract Background and Aims: This study assessed the efficacy and safety of up to 4 years of lamivudine treatment and the clinical relevance of the emergence of YMDD‐variant hepatitis B virus (HBV). Methods: Fifty‐eight Chinese adult patients with chronic hepatitis B (CHB) were randomized to lamivudine 100 mg/day for up to 5 years and were monitored for YMDD‐variant HBV, hepatitis B e antigen (HBeAg) seroconversion (loss of HBeAg and detectable antibody to HBeAg) and serum alanine aminotransferase (ALT) concentrations. Four‐year data are reported here. Results: The rate of HBeAg seroconversion increased with extended therapy and also with higher baseline ALT concentrations. YMDD‐variant HBV was detected in 67% (39/58) of patients at some point during treatment. After 4 years, a total of 47% (27/58) of patients achieved HBeAg seroconversion. Thirty‐three per cent (13/39) of patients with YMDD‐variant HBV achieved HBeAg seroconversion; this increased to 57% (8/14) in patients with moderately elevated (>2–5 × upper limit of normal) pre‐treatment ALT concentrations. The proportion of patients that achieved normal serum ALT increased from 29% (17/58) at baseline to 69% (31/45) following 4 years of treatment. That included 68% (23/34) of patients with YMDD‐variant HBV and 73% (8/11) of those without the variant. All patients receiving lamivudine had reduced serum concentrations of HBV‐DNA compared with baseline, despite the emergence of YMDD‐variant HBV in 39 patients. Lamivudine was generally well tolerated; there was little change in the number or type of drug‐related adverse events in the fourth year of the study. Conclusions: Despite the emergence of YMDD‐variant HBV, Chinese patients showed increased HBeAg seroconversion and improvement in ALT levels with an increased duration of treatment with lamivudine." @default.
• W2087416757 created "2016-06-24" @default.
• W2087416757 creator A5006202942 @default.
• W2087416757 creator A5022798871 @default.
• W2087416757 creator A5031767036 @default.
• W2087416757 creator A5038968081 @default.
• W2087416757 creator A5039932124 @default.
• W2087416757 creator A5043780319 @default.
• W2087416757 creator A5052834447 @default.
• W2087416757 creator A5070716628 @default.
• W2087416757 creator A5091803938 @default.
• W2087416757 creator A5091824422 @default.
• W2087416757 date "2004-10-08" @default.
• W2087416757 modified "2023-10-18" @default.
• W2087416757 title "Four years of lamivudine treatment in Chinese patients with chronic hepatitis B" @default.
• W2087416757 cites W1582508691 @default.
• W2087416757 cites W1725758063 @default.
• W2087416757 cites W1980912700 @default.
• W2087416757 cites W1985577568 @default.
• W2087416757 cites W1994294116 @default.
• W2087416757 cites W1999263104 @default.
• W2087416757 cites W2004139194 @default.
• W2087416757 cites W2032153894 @default.
• W2087416757 cites W2039294886 @default.
• W2087416757 cites W2044553804 @default.
• W2087416757 cites W2055270948 @default.
• W2087416757 cites W2062361210 @default.
• W2087416757 cites W2078344915 @default.
• W2087416757 cites W2080503023 @default.
• W2087416757 cites W2084713036 @default.
• W2087416757 cites W2095427717 @default.
• W2087416757 cites W2112150016 @default.
• W2087416757 cites W2123785057 @default.
• W2087416757 cites W2137544368 @default.
• W2087416757 cites W2159639664 @default.
• W2087416757 cites W2244010327 @default.
• W2087416757 cites W2318639814 @default.
• W2087416757 cites W2319441763 @default.
• W2087416757 cites W2338794667 @default.
• W2087416757 cites W3216648493 @default.
• W2087416757 doi "https://doi.org/10.1111/j.1440-1746.2004.03428.x" @default.
• W2087416757 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15482535" @default.
• W2087416757 hasPublicationYear "2004" @default.
• W2087416757 type Work @default.
• W2087416757 sameAs 2087416757 @default.
• W2087416757 citedByCount "243" @default.
• W2087416757 countsByYear W20874167572012 @default.
• W2087416757 countsByYear W20874167572013 @default.
• W2087416757 countsByYear W20874167572014 @default.
• W2087416757 countsByYear W20874167572015 @default.
• W2087416757 countsByYear W20874167572016 @default.
• W2087416757 countsByYear W20874167572017 @default.
• W2087416757 countsByYear W20874167572018 @default.
• W2087416757 countsByYear W20874167572019 @default.
• W2087416757 countsByYear W20874167572020 @default.
• W2087416757 countsByYear W20874167572021 @default.
• W2087416757 countsByYear W20874167572022 @default.
• W2087416757 countsByYear W20874167572023 @default.
• W2087416757 crossrefType "journal-article" @default.
• W2087416757 hasAuthorship W2087416757A5006202942 @default.
• W2087416757 hasAuthorship W2087416757A5022798871 @default.
• W2087416757 hasAuthorship W2087416757A5031767036 @default.
• W2087416757 hasAuthorship W2087416757A5038968081 @default.
• W2087416757 hasAuthorship W2087416757A5039932124 @default.
• W2087416757 hasAuthorship W2087416757A5043780319 @default.
• W2087416757 hasAuthorship W2087416757A5052834447 @default.
• W2087416757 hasAuthorship W2087416757A5070716628 @default.
• W2087416757 hasAuthorship W2087416757A5091803938 @default.
• W2087416757 hasAuthorship W2087416757A5091824422 @default.
• W2087416757 hasConcept C126322002 @default.
• W2087416757 hasConcept C159047783 @default.
• W2087416757 hasConcept C2522874641 @default.
• W2087416757 hasConcept C2775940106 @default.
• W2087416757 hasConcept C2777382497 @default.
• W2087416757 hasConcept C2777410769 @default.
• W2087416757 hasConcept C2777451964 @default.
• W2087416757 hasConcept C2777869810 @default.
• W2087416757 hasConcept C2780593183 @default.
• W2087416757 hasConcept C3020491458 @default.
• W2087416757 hasConcept C71924100 @default.
• W2087416757 hasConcept C90924648 @default.
• W2087416757 hasConceptScore W2087416757C126322002 @default.
• W2087416757 hasConceptScore W2087416757C159047783 @default.
• W2087416757 hasConceptScore W2087416757C2522874641 @default.
• W2087416757 hasConceptScore W2087416757C2775940106 @default.
• W2087416757 hasConceptScore W2087416757C2777382497 @default.
• W2087416757 hasConceptScore W2087416757C2777410769 @default.
• W2087416757 hasConceptScore W2087416757C2777451964 @default.
• W2087416757 hasConceptScore W2087416757C2777869810 @default.
• W2087416757 hasConceptScore W2087416757C2780593183 @default.
• W2087416757 hasConceptScore W2087416757C3020491458 @default.
• W2087416757 hasConceptScore W2087416757C71924100 @default.
• W2087416757 hasConceptScore W2087416757C90924648 @default.
• W2087416757 hasIssue "11" @default.
• W2087416757 hasLocation W20874167571 @default.
• W2087416757 hasLocation W20874167572 @default.
• W2087416757 hasOpenAccess W2087416757 @default.
• W2087416757 hasPrimaryLocation W20874167571 @default.

• next